Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affects |
animals
humans |
| gptkbp:alternativeName |
lockjaw
|
| gptkbp:category |
gptkb:disease
neurological disorder |
| gptkbp:causedBy |
gptkb:Clostridium_tetani
|
| gptkbp:commonIn |
developing countries
|
| gptkbp:complication |
gptkb:pneumonia
respiratory failure bone fractures |
| gptkbp:firstDescribed |
19th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tetanus
|
| gptkbp:ICD-10_code |
A35
|
| gptkbp:incubationPeriod |
3 to 21 days
|
| gptkbp:mortalityRate |
high without treatment
|
| gptkbp:prevention |
tetanus vaccine
|
| gptkbp:rareIn |
countries with high vaccination rates
|
| gptkbp:symptom |
fever
muscle stiffness difficulty swallowing high blood pressure sweating rapid heart rate muscle spasms lockjaw |
| gptkbp:transmission |
wound contamination
|
| gptkbp:transmittedBy |
person-to-person contact
|
| gptkbp:treatment |
antibiotics
wound care antitoxin muscle relaxants |
| gptkbp:vaccineType |
toxoid vaccine
|
| gptkbp:WHOClassification |
vaccine-preventable disease
|
| gptkbp:bfsParent |
gptkb:disease
gptkb:Vaccination |
| gptkbp:bfsLayer |
4
|